Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Global Medical REIT Inc is a reit-healthcare facilities business based in the US. Global Medical REIT shares (GMRE) are listed on the NYSE and all prices are listed in US Dollars. Global Medical REIT employs 22 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$15.85|
|52-week range||$11.44 - $15.85|
|50-day moving average||$15.25|
|200-day moving average||$14.79|
|Wall St. target price||$17.44|
|Dividend yield||$0.81 (5.37%)|
|Earnings per share (TTM)||$-0.09|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-08)||4.83%|
|1 month (2021-09-16)||3.12%|
|3 months (2021-07-16)||3.66%|
|6 months (2021-04-16)||10.84%|
|1 year (2020-10-16)||15.78%|
|2 years (2019-10-16)||38.67%|
|3 years (2018-10-16)||71.54%|
|5 years (2016-10-14)||68.80%|
Valuing Global Medical REIT stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Global Medical REIT's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Global Medical REIT's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $71 million.
The EBITDA is a measure of a Global Medical REIT's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$105.6 million|
|Operating margin TTM||31.18%|
|Gross profit TTM||$87.8 million|
|Return on assets TTM||1.9%|
|Return on equity TTM||0.09%|
|Market capitalisation||$970.7 million|
TTM: trailing 12 months
There are currently 1.0 million Global Medical REIT shares held short by investors – that's known as Global Medical REIT's "short interest". This figure is 5.8% up from 952,863 last month.
There are a few different ways that this level of interest in shorting Global Medical REIT shares can be evaluated.
Global Medical REIT's "short interest ratio" (SIR) is the quantity of Global Medical REIT shares currently shorted divided by the average quantity of Global Medical REIT shares traded daily (recently around 303550.30120482). Global Medical REIT's SIR currently stands at 3.32. In other words for every 100,000 Global Medical REIT shares traded daily on the market, roughly 3320 shares are currently held short.
However Global Medical REIT's short interest can also be evaluated against the total number of Global Medical REIT shares, or, against the total number of tradable Global Medical REIT shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Global Medical REIT's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Global Medical REIT shares in existence, roughly 20 shares are currently held short) or 0.0167% of the tradable shares (for every 100,000 tradable Global Medical REIT shares, roughly 17 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Global Medical REIT.
Find out more about how you can short Global Medical REIT stock.
Dividend payout ratio: 91.55% of net profits
Recently Global Medical REIT has paid out, on average, around 91.55% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 5.43% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Global Medical REIT shareholders could enjoy a 5.43% return on their shares, in the form of dividend payments. In Global Medical REIT's case, that would currently equate to about $0.81 per share.
Global Medical REIT's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Global Medical REIT's most recent dividend payout was on 7 October 2021. The latest dividend was paid out to all shareholders who bought their shares by 22 September 2021 (the "ex-dividend date").
Global Medical REIT's shares were split on a 1:400 basis on 16 November 2014. So if you had owned 400 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Global Medical REIT shares – just the quantity. However, indirectly, the new 39900% higher share price could have impacted the market appetite for Global Medical REIT shares which in turn could have impacted Global Medical REIT's share price.
Over the last 12 months, Global Medical REIT's shares have ranged in value from as little as $11.4374 up to $15.8521. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Global Medical REIT's is 0.7677. This would suggest that Global Medical REIT's shares are less volatile than average (for this exchange).
Global Medical REIT Inc. is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share. .
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.